Skip to main content Accessibility help
×
Home

Is cognitive behavioural therapy an effective complement to antidepressants in adolescents? A meta-analysis

  • Raffaella Calati (a1), Laura Pedrini (a2), Sara Alighieri (a3), Mariela Ivana Alvarez (a4), Lorenzo Desideri (a5), Daniele Durante (a6), Federica Favero (a7), Luisa Iero (a8), Giulia Magnani (a5) (a9), Valentina Pericoli (a10), Alexia Polmonari (a11), Roberta Raggini (a12), Elena Raimondi (a5), Valentina Riboni (a13), Maria Cristina Scaduto (a8), Alessandro Serretti (a1) and Giovanni De Girolamo (a2)...

Abstract

Calati R, Pedrini L, Alighieri S, Alvarez MI, Desideri L, Durante D, Favero F, Iero L, Magnani G, Pericoli V, Polmonari A, Raggini R, Raimondi E, Riboni V, Scaduto MC, Serretti A, De Girolamo G. Is cognitive behavioural therapy an effective complement to antidepressants in adolescents? A meta-analysis.

Objective: Evidence on effectiveness of combined treatments versus antidepressants alone in adolescents consists on a few studies in both major depressive and anxiety disorders. A meta-analysis of randomised 12-week follow-up studies in which antidepressant treatment was compared to combined treatment consisting of the same antidepressant with cognitive behavioural therapy has been performed.

Methods: Data were entered into the Cochrane Collaboration Review Manager software and were analysed within a random effect framework. A quality assessment has been performed through Jadad Scale.

Results: Higher global functioning at the Children's Global Assessment Scale was found in the combined treatment group (p < 0.0001) as well as higher improvement at the Clinical Global Impressions Improvement Scale (p = 0.04). No benefit of combined treatment was found on depressive symptomatology at the Children's Depression Rating Scale – Revised.

Conclusion: Combined treatment seems to be more effective than antidepressant alone on global functioning and general improvement in adolescents with major depressive and anxiety disorders.

Copyright

Corresponding author

Alessandro Serretti, MD, PhD, Institute of Psychiatry, University of Bologna, Viale Carlo Pepoli 5, 40123 Bologna, Italy. Tel: +39 051 6584233; Fax: +39 051 521030; E-mail: alessandro.serretti@unibo.it

References

Hide All
1.Michael, KD, Crowley, SL.How effective are treatments for child and adolescent depression? A meta-analytic review. Clin Psychol Rev 2002;22:247269.
2.Papanikolaou, K, Richardson, C, Pehlivanidis, A, Papadopoulou-Daifoti, Z.Efficacy of antidepressants in child and adolescent depression: a meta-analytic study. J Neural Transm 2006;113:399415.
3.Reinblatt, SP, Riddle, MA.The pharmacological management of childhood anxiety disorders: a review. Psychopharmacology 2007;191:6786.
4.Tsapakis, EM, Soldani, F, Tondo, L, Baldessarini, RJ.Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry 2008;193:1017.
5.Masi, G, Liboni, F, Brovedani, P.Pharmacotherapy of major depressive disorder in adolescents. Expert Opin Pharmacother 2010;11:375386.
6.Gentile, S.Antidepressant use in children and adolescents diagnosed with major depressive disorder: what can we learn from published data? Rev Recent Clin Trials 2010;5:6375.
7.Connolly, SD, Bernstein, GA.Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007;46:267283.
8.Birmaher, B, Brent, D, Bernet, W et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007;46:15031526.
9.NICE. Depression in Children and Young People. Identification and Management in Primary, Community and Secondary Care. 2005. URL http://www.nice.org.uk [accessed on April 2011].
10.Baldwin, DS, Anderson, IM, Nutt, DJ et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2005;19:567596.
11.Thorpe, L, Whitney, DK, Kutcher, SP, Kennedy, SH.Clinical guidelines for the treatment of depressive disorders. VI. Special populations. Can J Psychiatry 2001;46(Suppl. 1):63S76S.
12.Tandon, M, Pruett, JRAn overview of the use of antidepressants in children and adolescents. Mo Med 2008;105:7984.
13.van Engeland, H.Pharmacotherapy and behaviour therapy–competition or cooperation? Acta Paedopsychiatr 1993;56:123127.
14.March, J, Silva, S, Petrycki, S et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004;292:807820.
15.Brent, D, Emslie, G, Clarke, G et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA 2008;299:901913.
16.Goodyer, I, Dubicka, B, Wilkinson, P et al. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. BMJ 2007; 335:142.
17.Clarke, G, Debar, L, Lynch, F et al. A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. J Am Acad Child Adolesc Psychiatry 2005;44:888898.
18.Walkup, JT, Albano, AM, Piacentini, J et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 2008;359:27532766.
19.Dubicka, B, Elvins, R, Roberts, C, Chick, G, Wilkinson, P, Goodyer, IM.Combined treatment with cognitive-behavioural therapy in adolescent depression: meta-analysis. Br J Psychiatry 2010;197:433440.
20.Jadad, AR, Moore, RA, Carroll, D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:112.
21.Egger, M, Smith, GD, Phillips, AN.Meta-analysis: Principles and procedures. BMJ 1997;315:15331537.
22.Molenaar, PJ, Dekker, J, Van, R, Hendriksen, M, Vink, A, Schoevers, RA.Does adding psychotherapy to pharmacotherapy improve social functioning in the treatment of outpatient depression? Depress Anxiety 2007;24:553562.
23.Sharp, DM, Power, KG, Simpson, RJ, Swanson, V, Anstee, JA.Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care. Br J Gen Pract 1997;47:150155.
24.Curry, J, Rohde, P, Simons, A et al. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006;45:14271439.
25.Asarnow, JR, Emslie, G, Clarke, G et al. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry 2009;48:330339.
26.March, JS, Silva, S, Petrycki, S et al. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007;64:11321143.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed